Australian fresh dog food subscription company Lyka has announced the close of a US$47.5 million Series C funding round, positioning the business to push beyond its home market and broaden its product roadmap. The round was led by New York-based venture firm LGVP, with participation referenced publicly from groups including StepStone and Shearwater alongside earlier backers. While the raise was publicised this week, Startup Daily reported the round concluded in late January, and the company has framed the announcement as a milestone that reflects years of operational build-out rather than a sudden capital grab.
The Funding Round and Who Backed It
Startup Daily described the Series C as another LGVP-led round following Lyka’s $21.2 million Series B in 2022 and a 2023 top-up that brought that earlier round to $39 million. SmartCompany similarly reported the $47.5 million Series C and noted that details of the round’s scale and US investor participation were first reported by The Australian. Across the reports, the Series C lifts Lyka’s total capital raised to about $110 million, reinforcing the company’s ability to attract follow-on funding amid tighter venture conditions.
What Lyka Says It Has Built So Far
Lyka says it now serves more than 100,000 active dogs across Australia and has grown to roughly $142 million in annual recurring revenue, metrics it is using to signal scale and predictability. The business sells personalised meal plans direct-to-consumer on subscription, with pricing that varies by a dog’s profile, including weight, age, and activity levels. The company’s brand is also widely recognised for a provocative “dog poo” advertising campaign, which Startup Daily noted was banned by Netflix, underscoring Lyka’s willingness to market aggressively in a crowded category.
Technology, Vertical Integration, and Differentiation
Management has repeatedly described Lyka as a technology-enabled, vertically integrated operation that controls recipe development, manufacturing, and distribution while using customer data to tailor portions and dietary profiles. SmartCompany reported that Lyka points to B Corp certification and a carbon-negative claim as part of how it differentiates itself in the premium pet food market. That differentiation matters as more incumbents and startups compete for the same higher-spend pet owners who increasingly treat food choices as part of preventive health.
Where the New Capital Is Expected to Go
The company has linked the raise to global expansion and to clinical research aimed at dog health and longevity, suggesting the funding is intended for both go-to-market and scientific validation. Reporting cited by SmartCompany and The Australian tied the narrative to broader Australian pet spending estimates and highlighted Lyka’s ambition to expand product lines and geographies. The Australian also reported Lyka is backing peer-reviewed clinical trials with academic partners including the University of Sydney, the University of Queensland, and Massey University, indicating a push to turn “fresh feeding” claims into publishable evidence.
Signals From Company Leaders on LinkedIn
LinkedIn posts around the announcement leaned heavily into scale and impact metrics, including more than 100 million Australian-made meals delivered and claims that 96% of customers have observed measurable health improvements in their dogs. Lyka’s CEO Anna Podolsky framed the Series C as a step toward “new verticals” and credited execution across product, kitchens, tech, and customer teams, while emphasising that customer outcomes remain the focus. Separately, Lyka’s new CMO Cameron Luby echoed the same operating metrics and positioned the funding close as validation of the mission rather than a pivot away from it.
Lyka’s Series C is notable not just for its size, but for how it is being used to argue that a subscription-first, vertically integrated pet food model can reach meaningful scale in Australia. The company is now pairing growth rhetoric with a promise of clinical research, a combination that could help it stand out as premium pet nutrition becomes more contested and more scrutinised. If Lyka can translate funding into international traction and credible published outcomes, the round may mark a transition from local category leader to a broader health-and-wellness platform for pets.